3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Rhabdomyosarcoma
1
Recurrence
1
Recurent Vulvar Carcinoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Lymphoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
HIV Infections
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Eyelid Sebaceous Gland Carcinoma
1
Cervical Adenocarcinoma
1
Carcinoma, Ductal
1
Anus Neoplasms
1
Interventions
pembrolizumab
34
Cisplatin
29
Paclitaxel
15
Brachytherapy
15
Bevacizumab
15
Radiotherapy
14
Carboplatin
14
Blood Specimen Collection
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
11
Colposcopy
11
Nivolumab
10
Drug Therapy
10
atezolizumab
8
Human Papillomavirus DNA Tests
8
Gemcitabine
8
lenvatinib
7
Radiation
6
Platinum
6
Biopsy
6
toripalimab
5
cemiplimab
5
Surveys and Questionnaires
5
Standard of Care
5
Radiotherapy, Intensity-Modulated
5
Practice Guidelines as Topic
5
Patient Navigation
5
Fulvestrant
5
Fluorodeoxyglucose F18
5
zimberelimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Sentinel Lymph Node Biopsy
×
1 year
×
Clear all
NCT03719547
2025-07-01
RACC
Karolinska Institutet
Phase NA
Recruiting
800 enrolled